DRMA · Dermata Therapeutics, Inc.
$1.33
+0.05 (+3.91%)
At close · Jul 17
Going-concern doubt
— flagged May 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because of historical and expected operating losses and net operating cash flow deficits, there is substantial doubt about the Company's ability to continue as a going concern for one year from the issuance of the financial statements, which is not alleviated by management's plans.”View the 10-Q filed May 13, 2026
Market Cap
$5.35M
Shares
4,022,143
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-30 | 7,805 | $1.30 | $10,147 |
| 2026-06-29 | 28,345 | $1.29 | $36,565 |
| 2026-06-18 | 200 | $1.33 | $266 |
| 2026-06-15 | 243 | $1.18 | $287 |
| 2026-06-10 | 3,413 | $1.20 | $4,096 |
| 2026-06-09 | 2,326 | $1.21 | $2,814 |
| 2026-06-08 | 8,209 | $1.18 | $9,687 |
| 2026-06-05 | 6,607 | $1.25 | $8,259 |
| 2026-06-03 | 12,012 | $1.36 | $16,336 |
| 2026-06-01 | 1,058 | $1.30 | $1,375 |
| 2026-05-29 | 3,240 | $1.35 | $4,374 |
| 2026-05-22 | 2,346 | $1.24 | $2,909 |
| 2026-05-21 | 2,014 | $1.25 | $2,518 |
| 2026-05-20 | 236 | $1.18 | $278 |
| 2026-05-19 | 395 | $1.20 | $474 |
| 2026-05-18 | 2,891 | $1.19 | $3,440 |
| 2026-05-14 | 11,747 | $1.19 | $13,979 |
| 2026-05-05 | 3,969 | $1.30 | $5,160 |
| 2026-05-04 | 15,422 | $1.33 | $20,511 |
| 2026-05-01 | 15,093 | $1.37 | $20,677 |
| 2026-04-30 | 2,184 | $1.26 | $2,752 |
| 2026-04-29 | 1,702 | $1.26 | $2,145 |
| 2026-04-28 | 5,258 | $1.21 | $6,362 |
| 2026-04-27 | 1,327 | $1.24 | $1,645 |
| 2026-04-23 | 6,458 | $1.30 | $8,395 |
| 2026-04-21 | 3,365 | $1.34 | $4,509 |
| 2026-04-20 | 7,077 | $1.36 | $9,625 |
Showing 1–27 of 27 settlements